Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502742 | SCV000595529 | uncertain significance | not specified | 2017-02-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000881280 | SCV001024438 | likely benign | not provided | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000881280 | SCV001782794 | likely benign | not provided | 2021-03-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004629225 | SCV005134548 | likely benign | Inborn genetic diseases | 2024-03-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003979891 | SCV004792035 | likely benign | LAMB1-related disorder | 2020-07-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |